Sertraline Hydrochloride Tablet
Product Images NDC 50090-7693

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 50090-7693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907693)

Sertraline Hydrochloride 100 mg oral tablets packaging label from A-S Medication Solutions, Libertyville, IL. The label states each film-coated tablet contains 111.5 mg sertraline hydrochloride equivalent to 100 mg sertraline. It advises storage at 20 to 25 degrees Celsius and includes a quantity of 30 tablets. The label includes NDC 50090-7693.*

FDA Label Image

Image Description (Struct)

Chemical structure diagram of sertraline hydrochloride, depicting the molecular arrangement including two chlorine atoms attached to a biphenyl ring and a methylamino group on a cyclohexane ring.*

FDA Label Image

Table 3 (Table 3)

A data table titled 'Common Adverse Reactions in Pooled Placebo-Controlled Trials in Adults with MDD, OCD, PD, PTSD, SAD, and PMDD' comparing percentages of adverse reactions between sertraline hydrochloride (N=3066) and placebo (N=2293). It categorizes reactions under cardiac disorders, eye disorders, gastrointestinal disorders, general disorders, metabolism, nervous system, psychiatric, reproductive system, and skin disorders, showing higher rates for most reactions with sertraline hydrochloride.*

FDA Label Image

Table1 (Table1)

A table showing the recommended daily dosage of sertraline hydrochloride for adults and pediatric patients with conditions such as MDD, OCD, PD, PTSD, and SAD. It details starting doses and therapeutic ranges by indication and age group.*

FDA Label Image

Table2 (Table2)

A table titled 'Risk Differences of the Number of Cases of Suicidal Thoughts or Behaviors in Pooled Placebo-Controlled Trials of Antidepressants in Pediatric and Adult Patients.' It lists age ranges and corresponding drug-placebo differences in the number of patients with suicidal thoughts or behaviors per 1000 patients treated, showing increases compared to placebo for ages under 25 and decreases for ages 25 and older.*

FDA Label Image

Image Description (Table4)

A data table titled 'Most Common Sexual Adverse Reactions (≥2% and twice placebo) in Men or Women from sertraline hydrochloride Pooled Controlled Trials in Adults with MDD, OCD, PD, PTSD, SAD, and PMDD.' It compares the incidence rates of sexual adverse reactions in men and women treated with sertraline hydrochloride versus placebo, listing percentages for conditions like ejaculation failure, decreased libido, and erectile dysfunction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.